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Cover image: Two types of stem/progenitor cell niches in the pituitary gland have been proposed: the marginal cell layer (MCL-niche) 
and the dense cell clusters in the parenchyma (Parenchymal-niche). Using S100b/GFP-transgenic rats, a simple method was developed to 
isolate the parenchymal-niche as a cluster of SOX2-positive cell termed “parenchymal stem/progenitor cell (PS)-clusters”. PS-clusters were 
classified into the three subtypes based on the contents of S100b-GFP-positive cells: GFP-, mixed-GFP-, and null-GFP-clusters. Some of 
them showed differentiation capacity to hormone-producing cells in vitro differentiation assay. From article in this issue by Yoshida et al.,
Stem Cell Res. 17(1): 318-329.
